ATE363075T1 - Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung - Google Patents

Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung

Info

Publication number
ATE363075T1
ATE363075T1 AT04017838T AT04017838T ATE363075T1 AT E363075 T1 ATE363075 T1 AT E363075T1 AT 04017838 T AT04017838 T AT 04017838T AT 04017838 T AT04017838 T AT 04017838T AT E363075 T1 ATE363075 T1 AT E363075T1
Authority
AT
Austria
Prior art keywords
diagnosing
useful composition
composition therefor
treating metastases
smagp
Prior art date
Application number
AT04017838T
Other languages
English (en)
Inventor
Marie-Christine Rio
De Saint Hardouin Nesrin Tarbe
Ulrich Weidle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE363075T1 publication Critical patent/ATE363075T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04017838T 2003-07-28 2004-07-28 Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung ATE363075T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03016586 2003-07-28

Publications (1)

Publication Number Publication Date
ATE363075T1 true ATE363075T1 (de) 2007-06-15

Family

ID=34089578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04017838T ATE363075T1 (de) 2003-07-28 2004-07-28 Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung

Country Status (7)

Country Link
US (1) US20050032101A1 (de)
JP (1) JP4113167B2 (de)
CN (2) CN100541198C (de)
AT (1) ATE363075T1 (de)
CA (1) CA2469094A1 (de)
DE (1) DE602004006566T2 (de)
ES (1) ES2286539T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240052028A1 (en) * 2020-10-05 2024-02-15 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of anti-tumor phagocytosis
CN114933646A (zh) * 2022-06-22 2022-08-23 南通市第一老年病医院(上海大学附属南通医院、南通市第六人民医院、南通市肺科医院) Smagp蛋白多肽构建及其抗脂肪性肝病活性的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9904222A3 (en) * 1996-10-07 2000-08-28 Schering Corp Assay for the detection of antibodies against p53
WO2002008288A2 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
US6448041B1 (en) * 2000-12-18 2002-09-10 Incyte Genomics, Inc. Colon cancer marker

Also Published As

Publication number Publication date
DE602004006566D1 (de) 2007-07-05
ES2286539T3 (es) 2007-12-01
CN1576840A (zh) 2005-02-09
JP2005130848A (ja) 2005-05-26
CA2469094A1 (en) 2005-01-28
DE602004006566T2 (de) 2008-01-24
JP4113167B2 (ja) 2008-07-09
CN100541198C (zh) 2009-09-16
CN101649351A (zh) 2010-02-17
US20050032101A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
ATE516042T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von tumoren
ATE443260T1 (de) Kontrastmittel und verfahren zum imaging von naaldase oder psma
ATE522623T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren
ATE493433T1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
DE602004015064D1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
DE69807878D1 (de) Erkennung und Modulierung von IAPS und NAIP zur Diagnose und Behandlung von proliferativen Erkrankungen
DE602004016499D1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
TW200626900A (en) Wnt proteins and detection and treatment of cancer
DE60126248D1 (de) Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs
EP1578760A4 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE480641T1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
ATE375389T1 (de) Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
DE602004006566D1 (de) Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung
DE60226324D1 (de) Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE602004026683D1 (de) Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins
EP1363528A4 (de) Verfahren zur diagnose und behandlung von herzerkrankungen
EP1371729A3 (de) Verwendungen von TFF3 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
ATE414539T1 (de) Verfahren und materialien zur behandlung und diagnose von mit kallikrein-6 zusammenhängenden entzündlichen zuständen
ATE390435T1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
NO20075698L (no) Preparater og fremgangsmater til diagnostisering og behandling av tumor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties